Laser-Based 3D Bioprinting Market Size, Share, and Trends 2025 to 2034

The global laser-based 3D bioprinting market size accounted for USD 1.79 billion in 2025 and is forecasted to hit around USD 7.11 billion by 2034, representing a CAGR of 16.53% from 2025 to 2034. The North America market size was estimated at USD 754.60 million in 2024 and is expanding at a CAGR of 16.65% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : August 2025  |  Report Code : 6631  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Laser-based 3D Bioprinting Market 

5.1. COVID-19 Landscape: Laser-based 3D Bioprinting Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Laser-based 3D Bioprinting Market, By Technology / Printing Method

8.1. Laser-based 3D Bioprinting Market Revenue and Volume, by Technology / Printing Method

8.1.1. Laser-Induced Forward Transfer (LIFT) / Laser-assisted droplet transfer

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Laser stereolithography / Digital Light Processing (DLP) for bioprinting (photocrosslinking)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Holographic / volumetric laser printing (holographic light patterning)

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Hybrid systems (laser + extrusion / laser + inkjet combinations)

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Laser-based 3D Bioprinting Market, By Product Offering

9.1. Laser-based 3D Bioprinting Market Revenue and Volume, by Product Offering

9.1.1. Printing equipment / laser bioprinters

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Bioinks & biomaterials formulated for laser methods

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Consumables

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Software & process control

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Services

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Laser-based 3D Bioprinting Market, By Component / Subsystem 

10.1. Laser-based 3D Bioprinting Market Revenue and Volume, by Component / Subsystem

10.1.1. Laser sources & optics (UV, near-IR pulsed lasers, beam shaping)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Donor/acceptor substrate modules (coated films/carriers)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Photo-initiators, photocurable hydrogels & crosslinkers

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Precision stages & motion control

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Bioreactors / maturation modules (post-print culture)

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Laser-based 3D Bioprinting Market, By Application / End-Use

11.1. Laser-based 3D Bioprinting Market Revenue and Volume, by Application / End-Use

11.1.1. Tissue engineering & regenerative medicine (scaffolded tissues, grafts)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Drug discovery & in-vitro models (organoids, tumor models)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Personalized medicine / patient-specific implants (skin, cartilage)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Research & academic R&D (method development)

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Pre-clinical testing & contract research services

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Laser-based 3D Bioprinting Market, By End-User / Customer Segment

12.1. Laser-based 3D Bioprinting Market Revenue and Volume, by End-User / Customer Segment

12.1.1. Academic & government research institutes

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Pharmaceutical & biotech companies (drug screening)

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Contract research / contract development and manufacturing orgs (CROs/CDMOs)

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Hospitals & translational research centers (clinical-grade R&D)

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. OEMs and instrument integrators

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Laser-based 3D Bioprinting Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.1.2. Market Revenue and Volume Forecast, by Product Offering

13.1.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.1.4. Market Revenue and Volume Forecast, by Application / End-Use

13.1.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.1.6.2. Market Revenue and Volume Forecast, by Product Offering

13.1.6.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.1.6.4. Market Revenue and Volume Forecast, by Application / End-Use

13.1.6.5. Market Revenue and Volume Forecast, by End-User / Customer Segment  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.1.7.2. Market Revenue and Volume Forecast, by Product Offering

13.1.7.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.1.7.4. Market Revenue and Volume Forecast, by Application / End-Use

13.1.7.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.2.2. Market Revenue and Volume Forecast, by Product Offering

13.2.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.2.4. Market Revenue and Volume Forecast, by Application / End-Use  

13.2.5. Market Revenue and Volume Forecast, by End-User / Customer Segment  

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.2.6.2. Market Revenue and Volume Forecast, by Product Offering

13.2.6.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.2.7. Market Revenue and Volume Forecast, by Application / End-Use  

13.2.8. Market Revenue and Volume Forecast, by End-User / Customer Segment  

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.2.9.2. Market Revenue and Volume Forecast, by Product Offering

13.2.9.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.2.10. Market Revenue and Volume Forecast, by Application / End-Use

13.2.11. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.2.12.2. Market Revenue and Volume Forecast, by Product Offering

13.2.12.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.2.12.4. Market Revenue and Volume Forecast, by Application / End-Use

13.2.13. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.2.14.2. Market Revenue and Volume Forecast, by Product Offering

13.2.14.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.2.14.4. Market Revenue and Volume Forecast, by Application / End-Use

13.2.15. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.3.2. Market Revenue and Volume Forecast, by Product Offering

13.3.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.3.4. Market Revenue and Volume Forecast, by Application / End-Use

13.3.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.3.6.2. Market Revenue and Volume Forecast, by Product Offering

13.3.6.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.3.6.4. Market Revenue and Volume Forecast, by Application / End-Use

13.3.7. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.3.8.2. Market Revenue and Volume Forecast, by Product Offering

13.3.8.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.3.8.4. Market Revenue and Volume Forecast, by Application / End-Use

13.3.9. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.3.10.2. Market Revenue and Volume Forecast, by Product Offering

13.3.10.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.3.10.4. Market Revenue and Volume Forecast, by Application / End-Use

13.3.10.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.3.11.2. Market Revenue and Volume Forecast, by Product Offering

13.3.11.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.3.11.4. Market Revenue and Volume Forecast, by Application / End-Use

13.3.11.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.4.2. Market Revenue and Volume Forecast, by Product Offering

13.4.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.4.4. Market Revenue and Volume Forecast, by Application / End-Use

13.4.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.4.6.2. Market Revenue and Volume Forecast, by Product Offering

13.4.6.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.4.6.4. Market Revenue and Volume Forecast, by Application / End-Use

13.4.7. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.4.8.2. Market Revenue and Volume Forecast, by Product Offering

13.4.8.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.4.8.4. Market Revenue and Volume Forecast, by Application / End-Use

13.4.9. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.4.10.2. Market Revenue and Volume Forecast, by Product Offering

13.4.10.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.4.10.4. Market Revenue and Volume Forecast, by Application / End-Use

13.4.10.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.4.11.2. Market Revenue and Volume Forecast, by Product Offering

13.4.11.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.4.11.4. Market Revenue and Volume Forecast, by Application / End-Use

13.4.11.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.5.2. Market Revenue and Volume Forecast, by Product Offering

13.5.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.5.4. Market Revenue and Volume Forecast, by Application / End-Use

13.5.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.5.6.2. Market Revenue and Volume Forecast, by Product Offering

13.5.6.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.5.6.4. Market Revenue and Volume Forecast, by Application / End-Use

13.5.7. Market Revenue and Volume Forecast, by End-User / Customer Segment

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Technology / Printing Method

13.5.8.2. Market Revenue and Volume Forecast, by Product Offering

13.5.8.3. Market Revenue and Volume Forecast, by Component / Subsystem

13.5.8.4. Market Revenue and Volume Forecast, by Application / End-Use

13.5.8.5. Market Revenue and Volume Forecast, by End-User / Customer Segment

Chapter 14. Company Profiles

14.1. Poietis

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Prellis Biologics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Precise Bio / Precise Bio 3D (PreciseBio)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. BICO / CELLINK (BICO group)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. RegenHU (a 3D bioprinting specialist)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. 3D Bioprinting Solutions

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. 3DBio Therapeutics (3DBio / 3DBio Corp)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Organovo Holdings, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. EnvisionTEC / Desktop Metal (EnvisionTEC lab instruments)

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. CollPlant Ltd.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The laser-based 3D bioprinting market size is expected to increase from USD 1.54 billion in 2024 to USD 7.11 billion by 2034.

The laser-based 3D bioprinting market is expected to grow at a compound annual growth rate (CAGR) of around 16.53% from 2025 to 2034.

The major players in the laser-based 3D bioprinting market include Poietis, Prellis Biologics, Precise Bio / Precise Bio 3D (PreciseBio), BICO / CELLINK (BICO group), RegenHU (a 3D bioprinting specialist), 3D Bioprinting Solutions, 3DBio Therapeutics (3DBio / 3DBio Corp), Organovo Holdings, Inc., EnvisionTEC / Desktop Metal (EnvisionTEC lab instruments), CollPlant Ltd., Photon Jet Ltd., Orbotech (KLA) — laser/precision equipment supplier active in LIFT markets, Mycronic AB — laser/print head / micro-dispense equipment supplier, Precise Bio Inc. (equipment/biofabrication specialists), Cyfuse Biomedical (related high-precision printers; hybrid approaches), nScrypt (high-precision dispensing & hybrid systems), TeVido BioDevices (tissue-focused bioprinting), Vivax Bio / 3D Bio Corp (therapeutic-grade bioprinting ventures), Regenova (notable high precision / tissue printers / related companies), and Various contract / CDMO bioprinting service providers (representative: private specialist CDMOs in biofabrication).

The driving factors of the laser-based 3D bioprinting market are the by growing need for organ and tissue regeneration, pharmaceutical drug testing, and ongoing improvements in laser precision and biocompatible materials.

North America region will lead the global laser-based 3D bioprinting market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client